In Russellville, the grills have gone quiet at a longtime River Valley favorite.Feltner’s Whatta-burger, known for serving burgers and fries to generations of A Arkansas health leaders push to improve ...

The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...

Cybersecurity stocks slumped on Friday on a report that Anthropic is testing a powerful new artificial intelligence model called Mythos that presents potential security risks. The rise of AI is ...

UW-Superior snagged their second win of the season on Wednesday, beating St. Scholastica 64-56. The first half was a back and forth affair, but the Yellowjackets took an 11 point lead into halftime ...

Welcome to MythBusters, a Golf Digest+ series where we explore answers to some of golf’s most common questions through a series of tests with golfers and robots. Sometimes definitive, other times less ...

St. Scholastica men’s hockey entered Friday night with just one win to their name this season, but took down 12th ranked UW-Superior 3-1. The Yellowjackets struck first with a goal from Kade Shea just ...

Russia is stepping up its tests of systems designed to keep millions of people from accessing information online in times of political unrest, shutting off mobile internet access in the capital in ...

Traditional methods for creating dynamic drop-down lists in Excel, such as using INDIRECT or named ranges, often come with significant limitations. These approaches can break when tables are renamed, ...

SEATTLE — The rapidly expanding measles outbreak in both Washington and across the country has convinced UW Medicine to fast-track its testing efforts to help contain the spread. The Washington State ...

The risk of projectiles ricocheting into state Route 9 and I-87 led the U.S. Army branch contracting with a private security consulting firm to pull its support for a project to test-fire military ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.